fig3

Valve-in-valve transcatheter aortic valve replacement: the challenge of the next future

Figure 3. TAVR-in-TAVR after ViV TAVR. A degenerated Carpentier-Edwards Perimount 27 mm bioprosthesis (Edwards Lifesciences, Irvine, California, USA) treated with a first TAVR CoreValve Evolut R 29 mm (Medtronic, Minneapolis, Minnesota, USA) and a subsequent Sapien3 Ultra 26 mm (Edwards Lifesciences, Irvine, California, USA), due to damage to CoreValve leaflets after post-dilation by incomplete expansion with severe aortic regurgitation.

Mini-invasive Surgery
ISSN 2574-1225 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/